Troglitazone Increases VEGF in Diabetic Patients – (05-31-01)



Troglitazone Increases VEGF in Diabetic Patients

Remember the new-wonder drug for diabetes? Remember it was pulled off the market because of liver failure. Well, now we also find out that it may increase new blood vessels formation and actually lead to diabetic retinopathy!! It just amazes me how frequently we see drugs on the market that may work in the short term, but actually make the condition worse in the long run. Although this article does not mention it, new blood vessels formation is absolutely required for most tumor growths. Might this drug in the long run lead to increased rates and increased metastasis of certain cancers?

Diabetes — Abstracts: Emoto et al. 50 (5): 1166

Read entire article here

(for further reading on conjugated linoleic acid instead of troglitazone… Diabetes — Abstracts: Ryder et al. 50 (5): 1149 http://diabetes.diabetesjournals.org/cgi/content/abstract/50/5/1149

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Diabetes and Obesity Tips
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”